Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015)
Bausch Health Companies (BHC) posted Curent Deferred Tax Liability of $11.6 million for Q3 2015, down 69.63% sequentially from $38.2 million in Q2 2015, and down 38.95% YoY from $19.0 million in Q3 2014.
Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015) Analysis & Trends
Bausch Health Companies has reported Curent Deferred Tax Liability for 6 years, with the latest figure at $11.6 million in Q3 2015.
- Quarterly Curent Deferred Tax Liability fell 38.95% year-over-year to $11.6 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $11.6 million (down 38.95% YoY) and the FY2014 annual result came in at $10.7 million, down 83.79% from the prior year.
- Curent Deferred Tax Liability eased to $11.6 million in Q3 2015 per BHC's latest filing, from $38.2 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $66.0 million in Q4 2013 and troughed at $1.9 million in Q1 2011.
- A 5-year average of $15.3 million and a median of $8.8 million in 2012 frame the typical range for Curent Deferred Tax Liability.
- The sharpest annual moves came in 2013 and 2014: Curent Deferred Tax Liability surged 1398.98% in 2013, then slumped 83.79% in 2014.
- Over 5 years, Curent Deferred Tax Liability stood at $4.4 million in 2011, then declined by 0.79% to $4.4 million in 2012, then soared by 1398.98% to $66.0 million in 2013, then plunged by 83.79% to $10.7 million in 2014, then increased by 8.41% to $11.6 million in 2015.
- According to Business Quant data, Curent Deferred Tax Liability over the past three periods registered $11.6 million, $38.2 million, and $11.1 million for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 11.60 Mn |
| Sep 30, 2015 | 11.60 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Mar 31, 2013 | 4.29 Mn |
| Mar 31, 2013 | 4.29 Mn |